WADA 2026 Prohibited List Status (Section S0) Retatrutide is not currently named explicitly on the World Anti-Doping Agency 2025 or 2026 Prohibited Lists but falls within section S0 (Non-Approved Substances), which covers any pharmacological substance not currently approved by a governmental health authority for human therapeutic use
They actually work by affecting your hunger and appetite. Your body already makes GLP-1
Objective measures of awakening quality generally did not show significant changes based on psychological assessments
If you have questions about using Ozempic, its important to talk with your doctor about your concerns to ensure the best treatment plan for you and your condition
Daniel Bessesen, chief endocrinologist at the University of Colorado School of Medicine, May 6, 2026 Biomolecules, Weight Reduction with GLP-1 Agonists and Paths for Discontinuation While Maintaining Weight Loss, March 13, 2025 BMJ, Weight regain after cessation of medication for weight management: systematic review and meta-analysis, Jan
Missing your exact injection time by a few hours matters far less than missing entire doses